Recent Finacing
Recent Raise
Ellogon provides EIDOSTM, a CE‑IVDD‑certified AI platform that predicts patient responsiveness to cancer immunotherapy and integrates into clinical workflows for patient selection.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Ellogon AI.
